Experimental and Clinical Studies on the Significance of Endothelium-Derived Hyperpolarizing Factor (EDHF)
内皮源性超极化因子(EDHF)意义的实验和临床研究
基本信息
- 批准号:16209027
- 负责人:
- 金额:$ 30.7万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1.Role of Endothelial NO synthases system in the production of EDHF/H_2_O2(1)We have demonstrated that endothelial Cu, Zn-SOD plays an important role in the synthesis of EDHF/H_2O_2 not only in animals but also in humans.(2)We have demonstrated that long-term inhibition of Rho-kinase, which down-regulates eNOS, ameliorates endothelial function in various animal models of cardiovascular diseases.(3)We have demonstrated that EDHF/H_2O_2 is involved in the effects of ACE inhibitors.(4)We have developed mice lacking all NO synthases. Those mice showed impaired survival with hypertension and myocardial infarction.(5)In those triply NOSs-KO mice, EDHF responses were abolished, demonstrating the importance of endothelial NOSs system in the synthesis of EDHF/H_2O_2.2.Mechanisms of Physiological and Pathological H_2O_2 Synthesis(1)We were able to demonstrate that endothelial cells release H_2O_2 and NO at p.M order and that the two factors interact synergistically to maintain coronary flow in dogs in vivo.(2)We have demonstrated that other endothelial oxidases system (e.g.NADPH) are not involved in the EDHF/H_2O_2 responses.3.In vivo imaging of H_2O_2We were able to demonstrate endothelial production of H_2O_2 using DCF fluorescence imaging in vivo.4.Role of EDHF/H_2O_2 in animalsWe have demonstrated that EDHF/H_2O_2 plays an important protective role in myocardial ischemia/reperfusion and metabolic coronary vasodilatation as well.5.Role of EDHF/H_2O_2 in humans(1)We have demonstrated that in cultured vascular smooth muscle cells from human coronary arteries, estrogen down-regulates while nicotine up-regulates Rho-kinase.(2)We have demonstrated that selective Rho-kinase inhibitors acutely reduces pulmonary vascular resistance without systemic hemodynamic effects in patients with pulmonary hypertension.
1.内皮NO合成酶系统在EDHF/H_2O_2合成中的作用(1)我们已经证明内皮Cu, Zn-SOD在动物和人体内EDHF/H_2O_2合成中起重要作用。(2)我们已经证明,长期抑制rho激酶可以下调eNOS,改善各种心血管疾病动物模型的内皮功能。(3)我们已经证明EDHF/H_2O_2参与了ACE抑制剂的作用。(4)我们培育了缺乏所有NO合酶的小鼠。这些小鼠表现出高血压和心肌梗死的生存受损。(5)在三重NOSs- ko小鼠中,EDHF反应被消除,表明内皮NOSs系统在EDHF/H_2O_2.2合成中的重要性。生理和病理H_2O_2合成机制(1)内皮细胞按pm顺序释放H_2O_2和NO,两者协同作用维持狗体内冠状动脉血流。(2)我们已经证明其他内皮氧化酶系统(如nadph)不参与EDHF/H_2O_2反应。H_2O_2的体内成像我们可以用DCF荧光成像在体内证明内皮细胞产生H_2O_2。EDHF/H_2O_2在动物中的作用我们已经证明EDHF/H_2O_2在心肌缺血/再灌注和代谢性冠状动脉血管扩张中也有重要的保护作用。EDHF/H_2O_2在人血管平滑肌细胞中的作用(1)我们已经证明,在培养的人冠状动脉血管平滑肌细胞中,雌激素下调rho激酶,而尼古丁上调rho激酶。(2)我们已经证明,选择性rho激酶抑制剂在肺动脉高压患者中急性降低肺血管阻力而不影响全身血流动力学。
项目成果
期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Important role of hydrogen peroxide in pacing-induced metabolic coronary vasodilatation in dogs in vivo.
过氧化氢在狗体内起搏诱导的代谢性冠状血管舒张中的重要作用。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Yada T;Shimokawa H;et al.
- 通讯作者:et al.
Sustained elevation of serum cortisol level causes sensitization of coronary vasoconstricting responses in pigs in vivo - A possible link between stress and coronary vasospasm
- DOI:10.1161/01.res.0000244093.69985.2f
- 发表时间:2006-09-29
- 期刊:
- 影响因子:20.1
- 作者:Hizume, Takatoshi;Morikawa, Keiko;Shimokawa, Hiroaki
- 通讯作者:Shimokawa, Hiroaki
内科学(第9版) 欠陥の収縮弛緩と血圧調節機構
内科学(第9版)收缩/舒张缺陷与血压调节机制
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Ishii K;Tamaoka A;Otsuka F;Iwasaki N;Shin K;Matsui A;Endo G;Kumagai Y;Ishii T;Shoji S;Ogata T;Ishizaki M;Doi M;Shimojo N.;石崎 貴裕;Fukasawa M ed. al.;下川宏明
- 通讯作者:下川宏明
Endothelium-derived hydrogen peroxide accounts for the enhancing effect of an angiotensin converting enzyme inhibitor on EDHF-mediated responses in mice.
内皮衍生的过氧化氢解释了血管紧张素转换酶抑制剂对小鼠 EDHF 介导的反应的增强作用。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Fujiki T;Shimokawa H;et al.
- 通讯作者:et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHIMOKAWA Hiroaki其他文献
SHIMOKAWA Hiroaki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHIMOKAWA Hiroaki', 18)}}的其他基金
The possibility of pleiotropic effects of Novel Oral Anticoagulants (NOAC) on Rho-kinase-cyclophilin A System
新型口服抗凝剂 (NOAC) 对 Rho-激酶-亲环素 A 系统多效作用的可能性
- 批准号:
25670379 - 财政年份:2013
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
The role of SmgGDS in the pleiotropic effects by statins
SmgGDS 在他汀类药物多效性中的作用
- 批准号:
23659071 - 财政年份:2011
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Molecular mechanisms for NOSs-mediated responses in microvessels
NOS介导的微血管反应的分子机制
- 批准号:
22390154 - 财政年份:2010
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
International Collaboration Study on the Racial Difference in Coronary Vasospasm
冠状动脉痉挛种族差异的国际合作研究
- 批准号:
15256003 - 财政年份:2003
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Development of Nanomedicine for the Treatment of Cardiovascular Diseases
开发治疗心血管疾病的纳米药物
- 批准号:
13557068 - 财政年份:2001
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Role of Rho/Rho-kinase-mediated pathway in the pathogenesls of atherosclerosis
Rho/Rho激酶介导的通路在动脉粥样硬化发病机制中的作用
- 批准号:
13307024 - 财政年份:2001
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Basic and clinical studies on the role of inflammatory mechanisms in the pathogenesis ischemic heart disease
炎症机制在缺血性心脏病发病机制中的基础与临床研究
- 批准号:
12470158 - 财政年份:2000
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of Chronic Heart Failure Model Caused by Inflammatory Cytokines and Establishment of Prophylactic and Therapeutic Strategies for the Heart Failure
炎症细胞因子所致慢性心力衰竭模型的建立及心力衰竭防治策略的建立
- 批准号:
08557050 - 财政年份:1996
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The role of inflammatory mechanisms in the pathogenesis of ischemic heart disease. Basic and clinical studies.
炎症机制在缺血性心脏病发病机制中的作用。
- 批准号:
07457173 - 财政年份:1995
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Role of Inflammatory Cytokines in the Development and Progression of Ischemic Heart Diseases-Experimental and Clinical Studies-
炎症细胞因子在缺血性心脏病发生和进展中的作用-实验和临床研究-
- 批准号:
05454274 - 财政年份:1993
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
Peripheral circulatory regulation mechanism by a novel induced endothelium-derived hyperpolarizing factor in diastolic dysfunction
舒张功能障碍中新型诱导内皮源性超极化因子的外周循环调节机制
- 批准号:
21K11729 - 财政年份:2021
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functions of Nitric Oxide and Endothelium-derived Hyperpolarizing Factor are impaired in Poor Run-off Autogenous Rabbit Arterial Grafts
兔自体动脉移植物径流不良时一氧化氮和内皮源性超极化因子的功能受损
- 批准号:
17H04290 - 财政年份:2017
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Endothelium-derived hyperpolarizing factor in pulmonary artery hypertension
肺动脉高压中的内皮源性超极化因子
- 批准号:
25461621 - 财政年份:2013
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clarification of molecular mechanisms of endothelium-derived hyperpolarizing factor
阐明内皮源性超极化因子的分子机制
- 批准号:
16500266 - 财政年份:2004
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The endothelium-derived hyperpolarizing factor (EDHF) to maintain vascular tone actually exists
维持血管张力的内皮源性超极化因子(EDHF)确实存在
- 批准号:
16590210 - 财政年份:2004
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of Endothelium-Derived Hyperpolarizing Factor
内皮衍生的超极化因子的作用
- 批准号:
7039711 - 财政年份:2003
- 资助金额:
$ 30.7万 - 项目类别:
Cloning and functional analysis of the genes related to endothelium derived hyperpolarizing factor
内皮源性超极化因子相关基因的克隆及功能分析
- 批准号:
14570074 - 财政年份:2002
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of endothelium-derived hyperpolarizing factor (EDHF) in human arteries.
人体动脉中内皮源性超极化因子(EDHF)的鉴定。
- 批准号:
13670724 - 财政年份:2001
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cloning and functional analysis of the target ion channel of endothelium-derived hyperpolarizing factor
内皮源性超极化因子靶离子通道的克隆及功能分析
- 批准号:
12670076 - 财政年份:2000
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Modulation of intracellular Ca ion concentrations by endothelium-derived hyperpolarizing factor in vascular smooth muscle
血管平滑肌内皮源性超极化因子对细胞内钙离子浓度的调节
- 批准号:
04454150 - 财政年份:1992
- 资助金额:
$ 30.7万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)